Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3774-3785
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3774
Figure 5
Figure 5 Survival analysis was conducted in hepatocellular carcinoma patients with high or low phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 expression. A: Using the cancer genome atlas, hepatocellular carcinoma patients were subjected to overall survival analysis; B: Progression-free survival; and C: Relapse-free survival in those with high or low phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 expression. The median level was applied to patient clustering. HR: Hazard ratio.